• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿富汗赫拉特一家新冠病毒治疗中心住院患者不良结局的相关因素。

Factors associated with adverse outcomes among patients hospitalized at a COVID-19 treatment center in Herat, Afghanistan.

作者信息

Klein Ana, Bastard Mathieu, Hemat Hamayoun, Singh Saschveen, Muniz Bruno, Manangama Guyguy, Alayyan Amber, Tamanna Abdul Hakim, Barakzaie Bashir, Popal Nargis, Kakar Mohammad Azeem Zmarial, Poulet Elisabeth, Finger Flavio

机构信息

Epicentre, Paris, France.

Médecins sans Frontières, Kabul, Afghanistan.

出版信息

PLOS Glob Public Health. 2023 Aug 24;3(8):e0001687. doi: 10.1371/journal.pgph.0001687. eCollection 2023.

DOI:10.1371/journal.pgph.0001687
PMID:37619213
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10449473/
Abstract

Though many studies on COVID have been published to date, data on COVID-19 epidemiology, symptoms, risk factors and severity in low- and middle-income countries (LMICS), such as Afghanistan are sparse. To describe clinical characteristics, severity, and outcomes of patients hospitalized in the MSF COVID-19 treatment center (CTC) in Herat, Afghanistan and to assess risk factors associated with severe outcomes. 1113 patients were included in this observational study between June 2020 and April 2022. Descriptive analysis was performed on clinical characteristics, complications, and outcomes of patients. Univariate description by Cox regression to identify risk factors for an adverse outcome was performed. Adverse outcome was defined as death or transfer to a level 3 intensive care located at another health facility. Finally, factors identified were included in a multivariate Cox survival analysis. A total of 165 patients (14.8%) suffered from a severe disease course, with a median time of 6 days (interquartile range: 2-11 days) from admission to adverse outcome. In our multivariate model, we identified male gender, age over 50, high O2 flow administered during admission, lymphopenia, anemia and O2 saturation < = 93% during the first three days of admission as predictors for a severe disease course (p<0.05). Our analysis concluded in a relatively low rate of adverse outcomes of 14.8%. This is possibly related to the fact that the resources at an MSF-led facility are higher, in terms of human resources as well as supply of drugs and biomedical equipment, including oxygen therapy devices, compared to local hospitals. Predictors for severe disease outcomes were found to be comparable to other settings.

摘要

尽管迄今为止已经发表了许多关于新冠病毒的研究,但在阿富汗等低收入和中等收入国家(LMICs),关于新冠疫情的流行病学、症状、风险因素和严重程度的数据却很稀少。为了描述在阿富汗赫拉特的无国界医生组织新冠治疗中心(CTC)住院患者的临床特征、严重程度和结局,并评估与严重结局相关的风险因素。在2020年6月至2022年4月期间,1113名患者被纳入这项观察性研究。对患者的临床特征、并发症和结局进行了描述性分析。通过Cox回归进行单变量描述以确定不良结局的风险因素。不良结局定义为死亡或转至位于另一家医疗机构的三级重症监护病房。最后,将确定的因素纳入多变量Cox生存分析。共有165名患者(14.8%)经历了严重病程,从入院到出现不良结局的中位时间为6天(四分位间距:2-11天)。在我们的多变量模型中,我们确定男性、年龄超过50岁、入院期间给予的高氧流量、淋巴细胞减少、贫血以及入院前三天的氧饱和度<=93%是严重病程的预测因素(p<0.05)。我们的分析得出不良结局发生率相对较低,为14.8%。这可能与以下事实有关:与当地医院相比,无国界医生组织主导的机构在人力资源以及药品和生物医学设备供应(包括氧疗设备)方面资源更充足。发现严重疾病结局的预测因素与其他情况相当。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbf1/10449473/c9f1dd94d515/pgph.0001687.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbf1/10449473/c42cefc94fdf/pgph.0001687.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbf1/10449473/b5a4fd2efc94/pgph.0001687.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbf1/10449473/c9f1dd94d515/pgph.0001687.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbf1/10449473/c42cefc94fdf/pgph.0001687.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbf1/10449473/b5a4fd2efc94/pgph.0001687.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cbf1/10449473/c9f1dd94d515/pgph.0001687.g003.jpg

相似文献

1
Factors associated with adverse outcomes among patients hospitalized at a COVID-19 treatment center in Herat, Afghanistan.阿富汗赫拉特一家新冠病毒治疗中心住院患者不良结局的相关因素。
PLOS Glob Public Health. 2023 Aug 24;3(8):e0001687. doi: 10.1371/journal.pgph.0001687. eCollection 2023.
2
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.新冠康复者血浆或超免疫球蛋白用于新冠患者:快速综述
Cochrane Database Syst Rev. 2020 May 14;5(5):CD013600. doi: 10.1002/14651858.CD013600.
5
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19).人重组 C1 酯酶抑制剂(康奈司他)预防 COVID-19 住院患者严重 SARS-CoV-2 感染的研究方案:一项随机、平行分组、开放标签、多中心试验的结构摘要(PROTECT-COVID-19)。
Trials. 2021 Jan 4;22(1):1. doi: 10.1186/s13063-020-04976-x.
6
Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area.在中东呼吸综合征冠状病毒流行地区住院的 COVID-19 患者的临床特征和转归。
J Epidemiol Glob Health. 2020 Sep;10(3):214-221. doi: 10.2991/jegh.k.200806.002.
7
Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.挪威 2019 年冠状病毒病(NO COVID-19)实用开放性标签研究,评估硫酸羟氯喹在 2019 年冠状病毒病中度重症住院患者中的早期使用:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 5;21(1):485. doi: 10.1186/s13063-020-04420-0.
8
Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 Study.COVID-19 住院患者的心血管危险因素和临床结局:世界心脏联合会 COVID-19 研究的结果。
Glob Heart. 2022 Jun 15;17(1):40. doi: 10.5334/gh.1128. eCollection 2022.
9
Predictors of Severity in Covid-19 Patients in Casablanca, Morocco.摩洛哥卡萨布兰卡新冠肺炎患者严重程度的预测因素
Cureus. 2020 Sep 29;12(9):e10716. doi: 10.7759/cureus.10716.
10
Risk factors associated with intensive care unit (ICU) admission and in-hospital death among adults hospitalized with COVID-19: a two-center retrospective observational study in tertiary care hospitals.与 COVID-19 住院成人入住重症监护病房(ICU)和院内死亡相关的危险因素:两家三级医院的回顾性观察性研究。
Emerg Radiol. 2021 Aug;28(4):691-697. doi: 10.1007/s10140-021-01903-8. Epub 2021 Feb 3.

本文引用的文献

1
An Analysis of COVID-19 Mortality During the Dominancy of Alpha, Delta, and Omicron in the USA.美国 Alpha、Delta 和奥密克戎变异株流行期间 COVID-19 死亡率分析。
J Prim Care Community Health. 2023 Jan-Dec;14:21501319231170164. doi: 10.1177/21501319231170164.
2
Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom.英国与奥密克戎相关的新冠病毒症状变化
Clin Infect Dis. 2022 Aug 3;76(3):e133-41. doi: 10.1093/cid/ciac613.
3
COVID-19 morbidity in Afghanistan: a nationwide, population-based seroepidemiological study.
阿富汗的 COVID-19 发病情况:一项全国范围内基于人群的血清流行病学研究。
BMJ Open. 2022 Jul 27;12(7):e060739. doi: 10.1136/bmjopen-2021-060739.
4
Genomic surveillance of SARS-CoV-2 in US military compounds in Afghanistan reveals multiple introductions and outbreaks of Alpha and Delta variants.对驻阿富汗美军基地内的 SARS-CoV-2 进行基因组监测,揭示了 Alpha 和 Delta 变异株的多次传入和暴发。
BMC Genomics. 2022 Jul 15;23(1):513. doi: 10.1186/s12864-022-08757-5.
5
Clinical characteristics of the Omicron variant - results from a Nationwide Symptoms Survey in the Faroe Islands.奥密克戎变异株的临床特征——法罗群岛全国症状调查结果。
Int J Infect Dis. 2022 Sep;122:636-643. doi: 10.1016/j.ijid.2022.07.005. Epub 2022 Jul 8.
6
The Fourth Wave of the COVID-19 in Afghanistan: The Way Forward.阿富汗新冠疫情第四波:未来之路
Infect Drug Resist. 2022 Jun 28;15:3369-3371. doi: 10.2147/IDR.S365868. eCollection 2022.
7
Dynamics in COVID-19 symptoms during different waves of the pandemic among children infected with SARS-CoV-2 in the ambulatory setting.在门诊环境中,感染 SARS-CoV-2 的儿童在不同波次的 COVID-19 疫情期间症状的动态变化。
Eur J Pediatr. 2022 Sep;181(9):3309-3318. doi: 10.1007/s00431-022-04531-7. Epub 2022 Jul 1.
8
Differences in clinical features and mortality in very old unvaccinated patients (≥ 80 years) hospitalized with COVID-19 during the first and successive waves from the multicenter SEMI-COVID-19 Registry (Spain).在多中心 SEMI-COVID-19 注册中心(西班牙),首次和后续波次期间,≥ 80 岁的未接种疫苗的 COVID-19 住院老年患者(非常老)的临床特征和死亡率存在差异。
BMC Geriatr. 2022 Jun 30;22(1):546. doi: 10.1186/s12877-022-03191-4.
9
Estimation of the basic reproduction number of Alpha and Delta variants of COVID-19 pandemic in Iran.估算 COVID-19 大流行期间伊朗的 Alpha 和 Delta 变异株的基本繁殖数。
PLoS One. 2022 May 17;17(5):e0265489. doi: 10.1371/journal.pone.0265489. eCollection 2022.
10
Whole genome sequencing of SARS-CoV2 strains circulating in Iran during five waves of pandemic.伊朗在五次大流行期间流行的 SARS-CoV2 株的全基因组测序。
PLoS One. 2022 May 2;17(5):e0267847. doi: 10.1371/journal.pone.0267847. eCollection 2022.